WO1993022433A3 - Medicament for the gene-therapeutic treatment of human beings, animals and plants, especially to block virus multiplication and carcinogenes and process for producing the medicament - Google Patents
Medicament for the gene-therapeutic treatment of human beings, animals and plants, especially to block virus multiplication and carcinogenes and process for producing the medicament Download PDFInfo
- Publication number
- WO1993022433A3 WO1993022433A3 PCT/DE1993/000374 DE9300374W WO9322433A3 WO 1993022433 A3 WO1993022433 A3 WO 1993022433A3 DE 9300374 W DE9300374 W DE 9300374W WO 9322433 A3 WO9322433 A3 WO 9322433A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- medicament
- viruses
- animals
- human beings
- retro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
- C12N9/1276—RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP93911729A EP0677103A1 (en) | 1992-04-28 | 1993-04-28 | Medicament for the gene-therapeutic treatment of human beings, animals and plants, especially to block virus multiplication and carcinogenes and process for producing the medicament |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ATPCT/EP92/00923 | 1992-04-28 | ||
EP9200923 | 1992-04-28 | ||
DE4238879 | 1992-11-19 | ||
DEP4238879.1 | 1992-11-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1993022433A2 WO1993022433A2 (en) | 1993-11-11 |
WO1993022433A3 true WO1993022433A3 (en) | 1994-07-07 |
Family
ID=25920549
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DE1993/000374 WO1993022433A2 (en) | 1992-04-28 | 1993-04-28 | Medicament for the gene-therapeutic treatment of human beings, animals and plants, especially to block virus multiplication and carcinogenes and process for producing the medicament |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU4259193A (en) |
WO (1) | WO1993022433A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0650370A4 (en) * | 1992-06-08 | 1995-11-22 | Univ California | Methods and compositions for targeting specific tissue. |
DE19503082A1 (en) * | 1995-02-01 | 1996-08-08 | Univ Ludwigs Albert | Subject and method for preferentially transient expression and possible translation of specific RNA in the cytoplasmic region of higher eukaryotic cells |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0240332A2 (en) * | 1986-04-02 | 1987-10-07 | Pioneer Hi-Bred International, Inc. | Virus resistant plants having antisense RNA |
EP0278667A2 (en) * | 1987-02-09 | 1988-08-17 | Mycogen Plant Science, Inc. | Hybrid RNA virus |
WO1990005538A1 (en) * | 1988-11-14 | 1990-05-31 | The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce | Parvovirus capsids |
EP0387775A1 (en) * | 1989-03-16 | 1990-09-19 | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | Genetic construct for inhibiting RNA function |
WO1990012087A1 (en) * | 1989-04-05 | 1990-10-18 | Novacell Corporation | Infectious targetted replication-defective virion |
WO1992005266A2 (en) * | 1990-09-21 | 1992-04-02 | Viagene, Inc. | Packaging cells |
WO1992006180A1 (en) * | 1990-10-01 | 1992-04-16 | University Of Connecticut | Targeting viruses and cells for selective internalization by cells |
-
1993
- 1993-04-28 WO PCT/DE1993/000374 patent/WO1993022433A2/en not_active Application Discontinuation
- 1993-04-28 AU AU42591/93A patent/AU4259193A/en not_active Abandoned
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0240332A2 (en) * | 1986-04-02 | 1987-10-07 | Pioneer Hi-Bred International, Inc. | Virus resistant plants having antisense RNA |
EP0278667A2 (en) * | 1987-02-09 | 1988-08-17 | Mycogen Plant Science, Inc. | Hybrid RNA virus |
WO1990005538A1 (en) * | 1988-11-14 | 1990-05-31 | The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce | Parvovirus capsids |
EP0387775A1 (en) * | 1989-03-16 | 1990-09-19 | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | Genetic construct for inhibiting RNA function |
WO1990012087A1 (en) * | 1989-04-05 | 1990-10-18 | Novacell Corporation | Infectious targetted replication-defective virion |
WO1992005266A2 (en) * | 1990-09-21 | 1992-04-02 | Viagene, Inc. | Packaging cells |
WO1992006180A1 (en) * | 1990-10-01 | 1992-04-16 | University Of Connecticut | Targeting viruses and cells for selective internalization by cells |
Non-Patent Citations (1)
Title |
---|
GAREIS, M. ET AL.: "Homologous recombination of exogenous DNA fragments with genomic DNA in somatic cells of mice", CELLULAR AND MOLECULAR BIOLOGY, vol. 37, no. 2, 1991, pages 191 - 203, XP000406056 * |
Also Published As
Publication number | Publication date |
---|---|
WO1993022433A2 (en) | 1993-11-11 |
AU4259193A (en) | 1993-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU8335291A (en) | Drugs, their manufacture, and their use as painkillers and/or to treat inflammations in humans and animals | |
CA2214503A1 (en) | Method for treating tumors | |
IL105366A0 (en) | Methods and compositions for the treatment of diseases with interferon while reducing side effects | |
PT668763E (en) | USE OF FENSERIN FOR THE PREPARATION OF MEDICINES TO TREAT DISEASES OF KNOWLEDGE | |
ZA95679B (en) | Products containing G-CSF and TNF binding protein | |
DE3650505T2 (en) | AICA riboside for the prophylactic treatment of diseases with reduced blood flow. | |
WO1993022433A3 (en) | Medicament for the gene-therapeutic treatment of human beings, animals and plants, especially to block virus multiplication and carcinogenes and process for producing the medicament | |
DE69007065D1 (en) | Use of diadenosine 5 ', 5' '' - p1, p4-tetraphosphate for the manufacture of a medicament for the treatment of heart diseases. | |
GB8917323D0 (en) | Methods and pharmaceutical compositions for the treatment of ophthalmic diseases | |
US5547672A (en) | Accelerated wound healing | |
GR3032224T3 (en) | Therapeutic agent for threatened abortion. | |
AU5643299A (en) | Humic acid and its use in the treatment of various conditions | |
HK1042239A1 (en) | Bupropion to treat viral diseases. | |
EP0668771A4 (en) | Treatment of autoimmune diseases by inducing tolerance to cells, tissues and organs. | |
RU94006478A (en) | METHOD OF LIGHT THERAPY | |
Aliev et al. | The possibility of the use of interferon in the treatment of alcoholism. | |
RU92011168A (en) | PREPARATION FOR THE TREATMENT OF GYNECOLOGICAL DISEASES | |
RU2002131990A (en) | METHOD FOR TREATING VICTIMS OF A CRANIO-BRAIN INJURY IN THE EARLY POST-TRAUMATIC PERIOD | |
ZA938915B (en) | Treatment of viral infections by conjunctive therapy with acyclovir-like compounds and a 2'-vynyl substituted nucleoside analog | |
FARSHATOV | The role of radioprotectors in the effectiveness of the treatment of combined radiation injuries(Vliianie radioproektorov na effektivnost' lecheniia kombinirovannykh radiatsionnykh porazhenii(Obzor literatury)) | |
RU94043033A (en) | Method of immunohomeostasis correction and modulation at viscera organs and nervous system sickness | |
MD197G2 (en) | Preparation and method for hypogalactia treatment | |
Juca et al. | Antimicrobial therapy with cefoxitin sodium in vascular surgery and angiology: Clinical and laboratorial survey. | |
RU94002713A (en) | Method for treating children possessing elongated qt interval syndrome | |
RU92011195A (en) | METHOD FOR REDUCING THE DOSE OF CHEMICAL DRUGS USED TO TREAT INFECTIOUS DISEASES IN SIMULTANEOUSLY IMPROVING THEIR THERAPEUTIC EFFICIENCY |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AT AU BB BG BR BY CA CH CZ DK ES FI GB HU JP KP KR KZ LK LU MG MN MW NL NO NZ PL PT RO RU SD SE SK UA US VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AT AU BB BG BR BY CA CH CZ DK ES FI GB HU JP KP KR KZ LK LU MG MN MW NL NO NZ PL PT RO RU SD SE SK UA US VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
NENP | Non-entry into the national phase |
Ref country code: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1993911729 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1993911729 Country of ref document: EP |
|
WWR | Wipo information: refused in national office |
Ref document number: 1993911729 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1993911729 Country of ref document: EP |